A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway

Tumor-initiating cell (TIC) is a subpopulation of cells in tumors that are responsible for tumor initiation and progression. Recent studies indicate that hepatocellular carcinoma-initiating cells (HCICs) confer the high malignancy, recurrence and multi-drug resistance in hepatocellular carcinoma (HC...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Hong, Guo, Yuming, Li, Shu, Han, Ruiqin, Ying, Jianming, Zhu, Hai, Wang, Yuanyuan, Yin, Li, Han, Yuqing, Sun, Lingzhi, Wang, Zhaoyi, Lin, Qingcong, Bi, Xinyu, Jiao, Yuchen, Jia, Hongying, Zhao, Jianjun, Huang, Zhen, Li, Zhiyu, Zhou, Jianguo, Song, Wei, Meng, Kun, Cai, Jianqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741651/
https://www.ncbi.nlm.nih.gov/pubmed/26376676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741651/
https://www.ncbi.nlm.nih.gov/pubmed/26376676

Ejemplares similares